{"entity":{"id":"paper-el-assaad-ici-subsidy-sclc-lebanon-jcogo-2026","kind":"paper","name":"Immunotherapy access for small cell lung cancer in Lebanon after subsidies were withdrawn","aka":[],"tldr":"After Lebanon withdrew public subsidies for immunotherapy drugs in October 2022, three quarters of patients with extensive small cell lung cancer at one Beirut hospital did not receive the recommended treatment, and access depended on how they paid.","summary":"Published as \"Cancer Care in Crisis: How Subsidy Cuts Affected Immunotherapy Access for Patients With Small Cell Lung Cancer in Lebanon\". A mixed-methods study at Hôtel-Dieu de France University Hospital, Beirut: an interview with the hospital pharmacy and a retrospective cohort of patients diagnosed with extensive-stage small cell lung cancer from 2019 to 2024.","asOf":"2026-11-11","links":[{"label":"JCO Glob Oncol 2026","url":"https://doi.org/10.1200/go-25-00564"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/41604600/"}],"tags":[],"related":[],"cancers":["extensive-stage-sclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"JCO Global Oncology","year":2026,"doi":"10.1200/go-25-00564","pmid":"41604600","authors":"El Assaad N, Slim M, Yeretzian J, et al.","paperType":"real-world","findings":["Of 71 patients, 75% did not receive guideline-concordant optimal treatment.","Access to immune checkpoint inhibitors was associated with method of payment (P = .037) and public insurance coverage (P = .035).","Survival was higher with optimal treatment (P = .021) and among patients treated before the subsidy withdrawal (P = .037)."],"whatItMeans":"Shows in one hospital how withdrawing public subsidy for immunotherapy in October 2022 turned access into a question of who could pay.","caveats":["One hospital and 71 patients.","Retrospective; differences in survival may reflect other changes during the crisis."],"participants":71},"route":"/key-papers/paper-el-assaad-ici-subsidy-sclc-lebanon-jcogo-2026/","neighbours":{"cancer":[{"id":"extensive-stage-sclc","kind":"cancer","name":"Extensive-stage small-cell lung cancer","route":"/cancers/extensive-stage-sclc/"}],"institution":[{"id":"lebanon-ministry-of-public-health","kind":"institution","name":"Ministry of Public Health, Lebanon","route":"/institutions/lebanon-ministry-of-public-health/"}]}}